Metraipolis › archive › dc_136d2412c647

Adjuvant chemotherapy combined with pembrolizumab immunotherapy for primary triple-negative neuroendocrine carcinoma of the breast: a case report and… — Europe PMC PMID:42327776

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42327776
DOI
10.3389/fimmu.2026.1848635
License (as archived)
solo-consultazione
Archived
2026-10-31T19:28:49.509Z
SHA-256 of the archived text
b0258acfe0aeb135023a3c00036b12af6c8dec6450699d23f31a18ccc2a0c125
Stable URL of this page
https://metraipolis.com/documento/dc_136d2412c647

How to cite

Adjuvant chemotherapy combined with pembrolizumab immunotherapy for primary triple-negative neuroendocrine carcinoma of the breast: a case report and… — Europe PMC PMID:42327776 — Europe PMC (en), https://europepmc.org/article/MED/42327776 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_136d2412c647 (Metraipolis archive dc_136d2412c647, sha256 b0258acfe0aeb135023a3c00036b12af6c8dec6450699d23f31a18ccc2a0c125)
BibTeX
@misc{dc136d2412c647,
  title = {Adjuvant chemotherapy combined with pembrolizumab immunotherapy for primary triple-negative neuroendocrine carcinoma of the breast: a case report and… — Europe PMC PMID:42327776},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42327776},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_136d2412c647; sha256 b0258acfe0aeb135023a3c00036b12af6c8dec6450699d23f31a18ccc2a0c125},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42327776. Agents can read the archived copy with the MCP tool read_document.